title: Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms.
abstract: Clinical indications of amyloid imaging in atypical dementia remain unclear. We report a 68-year-old female without past psychiatric history who was hospitalized for auditory hallucinations and persecutory delusions associated with cognitive and motor deficits. Although psychotic symptoms resolved with antipsychotic treatment, cognitive and motor impairments remained. She further showed severe visuoconstructive and executive deficits, ideomotor apraxia, elements of Gerstmann's syndrome, bilateral agraphesthesia and discrete asymmetric motor deficits. Blood tests were unremarkable. Structural brain imaging revealed diffuse fronto-temporo-parietal atrophy, which was most severe in the parietal regions. Meanwhile, FDG-PET suggested asymmetrical fronto-temporo-parietal hypometabolism, with sparing of the posterior cingulate gyrus. A diagnosis of possible corticobasal syndrome (CBS) was made. Amyloid-PET using the novel tracer NAV4694 was ordered, and revealed significant deposition of fibrillar amyloid (SUVR 2.05). The primary diagnosis was CBS with underlying Alzheimer pathology and treatment with a cholinesterase inhibitor was initiated. Determination of underlying pathological CBS subtype is not simple even when based on extensive investigation including clinical presentation, atrophy patterns on MRI, and regional hypometabolism on FDG-PET. By contrast, amyloid imaging quickly confirmed Alzheimer pathology, and allowed rapid initiation of treatment in this complex case with early psychiatric symptoms. This case study illustrates the clinical utility of amyloid imaging in the setting of atypical cases seen in a tertiary memory clinic.
authors.affiliation: Faculty of Medicine, Laval University, Quebec City, QC, Canada ; Clinique Interdisciplinaire de Mémoire, Centre Hospitalier Universitaire (CHU) de Québec, Quebec City, QC, Canada.
authors.forename: M R
authors.initials: MR
authors.lastname: Bensaïdane
authors.affiliation: Clinique Interdisciplinaire de Mémoire, Centre Hospitalier Universitaire (CHU) de Québec, Quebec City, QC, Canada.
authors.forename: Fortin
authors.initials: F
authors.lastname: M-P
authors.affiliation: Clinique Interdisciplinaire de Mémoire, Centre Hospitalier Universitaire (CHU) de Québec, Quebec City, QC, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Damasse
authors.affiliation: Faculty of Medicine, Laval University, Quebec City, QC, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Chenard
authors.affiliation: Faculty of Medicine, Laval University, Quebec City, QC, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Dionne
authors.affiliation: Faculty of Medicine, Laval University, Quebec City, QC, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Duclos
authors.affiliation: Clinique Interdisciplinaire de Mémoire, Centre Hospitalier Universitaire (CHU) de Québec, Quebec City, QC, Canada.
authors.forename: R W
authors.initials: RW
authors.lastname: Bouchard
authors.affiliation: Clinique Interdisciplinaire de Mémoire, Centre Hospitalier Universitaire (CHU) de Québec, Quebec City, QC, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Laforce
keywords: Alzheimer’s disease; Amyloid-PET; Neurodegenerative disease